BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1442877)

  • 21. The UNOS Scientific Renal Transplant Registry--1990.
    Cecka JM; Terasaki PI
    Clin Transpl; 1990; ():1-10. PubMed ID: 2103135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplantation of a cadaveric polycystic kidney in a patient with autosomal dominant polycystic kidney disease: long-term outcome.
    Powell CR; Tata S; Govani MV; Chien GW; Orvieto MA; Shalhav AL
    Transplant Proc; 2004 Jun; 36(5):1288-92. PubMed ID: 15251314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database.
    Bunnapradist S; Chung P; Peng A; Hong A; Chung P; Lee B; Fukami S; Takemoto SK; Singh AK
    Transplantation; 2006 Sep; 82(5):612-8. PubMed ID: 16969282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful long-term outcome with 0-haplotype-matched living-related kidney donors.
    Jones JW; Gillingham KJ; Sutherland DE; Payne WD; Dunn DL; Gores PF; Gruessner RW; Najarian JS; Matas AJ
    Transplantation; 1994 Feb; 57(4):512-5. PubMed ID: 8116034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
    Gruessner AC; Sutherland DE
    Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Race effects.
    Koyama H; Cecka JM
    Clin Transpl; 1991; ():269-80. PubMed ID: 1820122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of ESRD in patients with autosomal dominant polycystic kidney disease.
    Alam A; Perrone RD
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):164-72. PubMed ID: 20219619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Renal transplantation in patients with autosomal dominant polycystic kidney disease: pre-transplantation evaluation and follow-up].
    Bretagnol A; Büchler M; Boutin JM; Nivet H; Lebranchu Y; Chauveau D
    Nephrol Ther; 2007 Dec; 3(7):449-55. PubMed ID: 18047999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal transplantation in children with lupus nephritis.
    Gipson DS; Ferris ME; Dooley MA; Huang K; Hogan SL
    Am J Kidney Dis; 2003 Feb; 41(2):455-63. PubMed ID: 12552510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications.
    Taylor M; Johnson AM; Tison M; Fain P; Schrier RW
    Am J Kidney Dis; 2005 Sep; 46(3):415-23. PubMed ID: 16129202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of donor age on outcome of kidney transplantation. A two-year analysis of transplants reported to the United Network for Organ Sharing Registry.
    Alexander JW; Bennett LE; Breen TJ
    Transplantation; 1994 Mar; 57(6):871-6. PubMed ID: 8154034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pediatric kidney transplantation and living donors--invaluable by virtue of necessity].
    Leumann E; Goetschel P; Neuhaus TJ; Ambühl PM; Candinas D
    Schweiz Med Wochenschr; 2000 Oct; 130(43):1581-9. PubMed ID: 11100511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant nephrectomy of massively enlarged kidneys and renal transplantation in autosomal dominant polycystic kidney disease.
    Tabibi A; Simforoosh N; Abadpour P; Gholamrezaie HR; Nafar M
    Transplant Proc; 2005 Sep; 37(7):2939-40. PubMed ID: 16213267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-transplant risk factors for renal allograft dysfunction at one year in Indian patients.
    Prabhu R; John GT; Shankar V; Thomas PP; Abi Abraham M; Jeyaseelan L; Jacob CK
    Natl Med J India; 2001; 14(1):18-21. PubMed ID: 11242692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.
    Foley DP; Patton PR; Meier-Kriesche HU; Li Q; Shenkman B; Fujita S; Reed A; Hemming AW; Kim RD; Howard RJ
    Clin Transpl; 2005; ():101-9. PubMed ID: 17424728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database.
    Chavalitdhamrong D; Gill J; Takemoto S; Madhira BR; Cho YW; Shah T; Bunnapradist S
    Transplantation; 2008 Jun; 85(11):1573-9. PubMed ID: 18551062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretransplant nephrectomy in patients with autosomal dominant polycystic kidney disease.
    Rozanski J; Kozlowska I; Myslak M; Domanski L; Sienko J; Ciechanowski K; Ostrowski M
    Transplant Proc; 2005 Mar; 37(2):666-8. PubMed ID: 15848495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2002; ():1-20. PubMed ID: 12971433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Afghan refugees in Iran model renal transplantation program: ethical considerations.
    Ghods AJ; Nasrollahzadeh D; Kazemeini M
    Transplant Proc; 2005 Mar; 37(2):565-7. PubMed ID: 15848458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic testing in the assessment of living related kidney donors at risk of autosomal dominant polycystic kidney disease.
    Simms RJ; Travis DL; Durkie M; Wilson G; Dalton A; Ong AC
    Transplantation; 2015 May; 99(5):1023-9. PubMed ID: 25340609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.